The thymus is an intricate organ consisting of a diverse population of thymic epithelial cells…
sciencecityMarch 29, 2023
Explore Now
News and Articles
Ghrelin is a potential therapy for cachexia due to its orexigenic properties and anabolic effects…
sciencecityMarch 28, 2023
Clay Siegall is proud of his legacy as co-founder and longtime CEO of Seagen, the largest…
sciencecityMarch 28, 2023
A potential new genetic risk factor for amyotrophic lateral sclerosis (ALS) has been discovered by researchers at…
sciencecityMarch 27, 2023
Today’s installment is with BBI member Tina Lockwood, Associate Professor in the Department of Laboratory Medicine…
kchenApril 8, 2021
Seattle-based biotech company Impel NeuroPharma is set to go public. The company, which develops drugs for central…
kchenApril 7, 2021
Umoja Biopharma, a biotechnology company pioneering an integrated, in vivo immunotherapy platform, today announced the…
kchenApril 7, 2021
Form follows function in the latest chapter of a fruitful collaboration involving two University of…
kchenApril 7, 2021
News and Articles
In an important development for biomedical imaging research, Paul Kinahan, joint professor of Bioengineering and…
karnottNovember 21, 2023
In late October, PNRI celebrated recent achievements and ongoing innovation in the field of genetic…
karnottNovember 20, 2023
Phase Genomics, Inc., a global provider of industry-leading genomic solutions, has been awarded the “Metagenomics…
karnottNovember 20, 2023
Upcoming Events in Seattle
Stay up-to-date with all of the life science events taking place in Seattle with the Science in Seattle events calendar!
